Financial Gravity Asset Management’s CareDx CDNA Stock Holding History
Bought
Maintained
Sold
Other funds holding CDNA
AIM
BG
AC
NAMA
GS
Financial Gravity Asset Management's CDNA Position: Q1 2023 in Review
Financial Gravity Asset Management sold out of CareDx (CDNA) in Q1 2023, closing a stake of 11 shares — an estimated $19 sold.
Financial Gravity Asset Management first reported a position in CDNA in Q3 2019 and held it in 2 quarters. The position peaked at $19 in Q4 2022. 156 funds tracked by Wall St. Rank hold CDNA as of Q1 2023.
- Financial Gravity Asset Management reported no remaining CareDx position as of Q1 2023 after selling out during the quarter.
- Financial Gravity Asset Management sold 11 CareDx shares in Q1 2023, an estimated $19.
- Financial Gravity Asset Management first reported a position in CareDx in Q3 2019 and held it in 2 quarters.
- Financial Gravity Asset Management's CareDx position peaked at $19 in Q4 2022.
- 156 funds tracked by Wall St. Rank held CareDx as of Q1 2023.
Based on Financial Gravity Asset Management's 13F filing for Q1 2023, filed 12 May 2023.